v3.24.3
Shareholders' Equity (Tables)
 9 Months Ended
Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table includes a summary of the option activity during the nine months ended October 31, 2024:
Number of Options
Weighted-Average Exercise Price
Outstanding at January 31, 20243,517,075 $24.77 
Granted— — 
Exercised(712,219)15.38 
Forfeited or canceled(163,276)61.25 
Outstanding at October 31, 20242,641,580 25.04 
Exercisable at October 31, 20242,466,276 22.86 
Schedule of Restricted Stock Units Award Activity
The following table includes a summary of the RSU activity during the nine months ended October 31, 2024:
Number of Shares
Weighted-Average Grant-Date Fair Value
Outstanding at January 31, 20248,798,624 $45.41 
Granted1,085,216 42.69 
Vested(2,874,718)46.43 
Forfeited or canceled(1,184,921)44.72 
Outstanding at October 31, 20245,824,201 44.53 
Schedule of Performance Share Units Activity
The following table includes a summary of the PSU activity during the nine months ended October 31, 2024:
Number of SharesWeighted-Average Grant-Date Fair Value
Outstanding at January 31, 2024321,463 $50.54 
Granted194,624 34.27 
Vested— — 
Forfeited or canceled(63,206)50.61 
Outstanding at October 31, 2024452,881 43.53 
Schedule of Shares Available for Issuance Under ESPP
The following table includes a summary of the activity of shares available for issuance under the 2018 Plan and the ESPP during the nine months ended October 31, 2024:
2018 Plan
ESPP
Balance at January 31, 202418,985,254 5,572,546 
Authorized6,844,200 1,368,840 
Granted(1,279,840)(298,236)
Forfeited or canceled1,411,403 — 
Balance at October 31, 202425,961,017 6,643,150 
Schedule of Share-based Compensation Expense
Share-based compensation expense included in the condensed consolidated statements of operations was as follows (in thousands):
Three Months Ended October 31,Nine Months Ended October 31,
2024202320242023
Cost of subscription revenue$2,983 $3,164 $9,055 $9,980 
Cost of professional services revenue1,485 1,777 4,734 5,602 
Research and development17,763 17,220 54,036 52,263 
Sales and marketing14,453 17,462 45,472 55,505 
General and administrative9,151 10,024 29,827 30,099 
Total share-based compensation expense$45,835 $49,647 $143,124 $153,449